A detailed history of Pineridge Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pineridge Advisors LLC holds 141 shares of MRK stock, worth $13,579. This represents 0.01% of its overall portfolio holdings.

Number of Shares
141
Previous 182 22.53%
Holding current value
$13,579
Previous $22.5 Million 28.94%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$111.15 - $128.97 $4,557 - $5,287
-41 Reduced 22.53%
141 $16 Million
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $371 - $398
-3 Reduced 1.62%
182 $22.5 Million
Q1 2024

May 16, 2024

SELL
$113.24 - $131.95 $38,048 - $44,335
-336 Reduced 64.49%
185 $24.4 Million
Q4 2023

Mar 01, 2024

BUY
$100.18 - $109.02 $52,193 - $56,799
521 New
521 $56.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pineridge Advisors LLC Portfolio

Follow Pineridge Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pineridge Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pineridge Advisors LLC with notifications on news.